GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adocia (XPAR:ADOC) » Definitions » Price-to-Tangible-Book

Adocia (XPAR:ADOC) Price-to-Tangible-Book : (As of Dec. 12, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Adocia Price-to-Tangible-Book?

As of today (2024-12-12), Adocia's share price is €6.85. Adocia's Tangible Book per Share of Jun. 2024 for the quarter that ended in Jun. 2024 was €-0.51. Hence, Adocia's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Adocia's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Adocia's highest Price to Tangible Book Ratio was 119.73. The lowest was 2.46. And the median was 3.87.

XPAR:ADOC's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.93
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Adocia's share price is €6.85. Adocia's Book Value per Sharefor the quarter that ended in Jun. 2024 was €-0.51. Hence, Adocia's P/B Ratio of today is .


Adocia Price-to-Tangible-Book Historical Data

The historical data trend for Adocia's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adocia Price-to-Tangible-Book Chart

Adocia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.46 9.22 - - -

Adocia Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Adocia's Price-to-Tangible-Book

For the Biotechnology subindustry, Adocia's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adocia's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adocia's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Adocia's Price-to-Tangible-Book falls into.



Adocia Price-to-Tangible-Book Calculation

Adocia's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2024 )
=6.85/-0.513
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Adocia Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Adocia's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Adocia Business Description

Industry
Traded in Other Exchanges
Address
115 Avenue Lacassagne, Lyon, FRA, 69003
Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. The firm has developed Biochaperone, a proprietary technology platform to enhance the effectiveness of therapeutic proteins. The company's clinical pipeline includes Biochaperone Lispro, Biochaparone Combo, Biochaparone Glucagon, and others. Its pre-clinical pipeline includes BioChaperone LisPram, BioChaperone Glargine GLP-1, and BioChaperone Glucagon GLP1. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.